Group 1 - The core point of the article is that Xishongjiang has reduced its stake in SenSong International (02155) by selling 100,000 shares at an average price of HKD 10.49 per share, totaling HKD 1.049 million [1] - After the reduction, Xishongjiang's latest shareholding is 7.077 million shares, representing a holding percentage of 0.57% [1]

股份發行人及根據《上市規則》第十九B章上市的香港預託證券發行人的證券變動月報表 | 截至月份: | 2025年12月31日 | 狀態: 新提交 | | --- | --- | --- | | 致：香港交易及結算所有限公司 | | | | 公司名稱: | 森松國際控股有限公司 | | | 呈交日期: | 2026年1月2日 | | | I. 法定/註冊股本變動 | 不適用 | | | 備註： | | | | 因森松國際控股有限公司("本公司")是於香港註冊成立的公司, "法定股本"之概念不適用於本公司。 | | | FF301 第 1 頁 共 10 頁 v 1.1.1 FF301 II. 已發行股份及/或庫存股份變動 | 1. 股份分類 | 普通股 | 股份類別 | 不適用 | | 於香港聯交所上市 (註1) | 是 | | | --- | --- | --- | --- | --- | --- | --- | --- | | 證券代號 (如上市) | 02155 | 說明 | | | | | | | | | 已發行股份（不包括庫存股份）數目 | | 庫存股份數目 | | 已發行股份總數 | | | 上月底結存 ...

Group 1 - The core point of the article highlights that Southbound funds have reduced their holdings in Sensong International (02155.HK) by 2.4622 million shares on December 30, with a total net reduction of 3.5512 million shares over the last five trading days [1] - Over the past 20 trading days, Southbound funds have reduced their holdings on 16 occasions, resulting in a cumulative net reduction of 11.6012 million shares [1] - As of now, Southbound funds hold 18.7 million shares of Sensong International, accounting for 15.01% of the company's total issued ordinary shares [1] Group 2 - Sensong International Holdings Limited primarily engages in the manufacturing of pressure equipment and provides comprehensive pressure equipment solutions [1] - The company's main products include traditional pressure equipment such as heat exchangers, vessels, reactors, and towers, as well as modular pressure equipment including process modules and skid-mounted units [1] - Additionally, the company offers value-added services such as design, validation, and maintenance of pressure equipment, operating in both domestic and overseas markets [1]

Group 1 - The company announced the passing of its independent non-executive director, Shinichiro Sugano, on December 24, 2025 [1]

Group 1 - The company announced the passing of its independent non-executive director, Mr. Shinichiro Sugano, on December 24, 2025 [1]

Group 1 - The company announced the passing of its independent non-executive director, Mr. Shinichiro Sugano, on December 24, 2025 [1]

Morimatsu International Holdings Company Limited 森松國際控股有限公司 （ 於 香 港 註 冊 成 立 的 有 限 公 司 ） （「本公司 」） （股 份 代 號：2155） 董事名單與其角色及職能 本公司董事（「董事」）會（「董事會」）成員載列如下： 獨立非執行董事： 陳遠秀女士 于建國先生 董事會已設立三個常務董事委員會。下表提供若干董事會成員於該等委員會 所擔任職務的資料： | 董事 | | 董事委員會 | 審核委員會 | 薪酬委員會 | 提名委員會 | | --- | --- | --- | --- | --- | --- | | 松久晃基先生 | （主席） | | M | M | C | | 陳遠秀女士 | | | C | | M | | 于建國先生 | | | | C | M | 附註： C：相關委員會主席 M：相關委員會成員 2025年12月29日 執行董事： 西松江英先生 平澤準悟先生 湯衛華先生 盛曄先生 川島宏貴先生 非執行董事： 松久晃基先生 （主席） ...

香港交易及結算所有限公司及香港聯合交易所有限公司對本公告的內容概不負責，對其準確 性或完整性亦不發表任何聲明，並明確表示，概不對因本公告全部或任何部份內容而產生或 因倚賴該等內容而引致的任何損失承擔任何責任。 Morimatsu International Holdings Company Limited 森松國際控股有限公司 （ 於 香 港 註 冊 成 立 的 有 限 公 司 ） （股 份 代 號：2155） – 1 – 菅野先生的辭世致使本公司不再符合聯交所證券上市規則（「上市規則」）之規定， 即(i)上市規則第3.10(1)條項下的獨立非執行董事最低人數規定；(ii)上市規則第 3.10A條項下的獨立非執行董事必須佔董事會成員人數至少三分之一的規定；(iii) 上市規則第3.21條及審核委員會職權範圍項下的審核委員會最低成員人數規定 及組成要求的規定；及(iv)上市規則第3.25條及薪酬委員會職權範圍項下的薪 酬委員會組成要求的規定。本公司將合理地盡力適時委任足夠人數的獨立非 執行董事，以符合上市規則的相關規定。本公司將於適當時候刊發進一步公告。 承董事會命 森松國際控股有限公司 行政總裁兼執行董事 西 ...

Core Viewpoint - The pharmaceutical equipment industry is experiencing a recovery, with many listed companies showing a turning point in performance due to a resurgence in demand as the pharmaceutical sector enters an expansion phase [1][2][10]. Industry Recovery - The pharmaceutical equipment sector was previously in a downturn due to the global biopharmaceutical industry's cyclical decline, but by Q3 2025, most related companies have shown signs of recovery [2][12]. - The global capacity is entering an expansion phase, which is expected to significantly benefit the pharmaceutical equipment industry [1][15]. Company Performance - In Q3 2025, Chutian Technology reported revenues of 1.479 billion yuan and a net profit of 96.77 million yuan, with year-on-year growth of 10.17% in revenue and 192.50% in net profit [3][12]. - Dongfulong achieved revenues of 1.275 billion yuan and a net profit of 85.66 million yuan in Q3 2025, marking a significant improvement compared to the previous quarter [3][13]. - Despite a decline in revenue and net profit in the first half of 2025, Sensong International's new orders reached a historical high, driven by a surge in pharmaceutical contracts [4][14]. Contract Liabilities - Both Chutian Technology and Dongfulong have seen a continuous increase in contract liabilities, indicating a growing backlog of orders [4][13]. Capacity Expansion Plans - Major domestic companies like WuXi Biologics and Kangfang Biologics are set to initiate new capacity expansions in 2024, with significant increases in production capabilities [5][15]. - Internationally, multinational pharmaceutical companies are also advancing their global capacity layouts to enhance supply chain resilience, with substantial investments planned in the U.S. [5][16]. International Market Opportunities - The global pharmaceutical equipment market is projected to grow significantly, with domestic companies having substantial opportunities for international expansion [7][17]. - Domestic brands are increasingly competitive, with a notable shift towards local production capabilities, indicating a strong potential for import substitution [7][17]. Strategic Internationalization - Companies like Sensong International are leveraging their long-term technological expertise to enhance their international presence, aiming to capture new orders amid the ongoing industry transition [8][18]. - Dongfulong and Chutian Technology are actively expanding their overseas operations, with Dongfulong already achieving significant sales in international markets [9][19].

Group 1 - The core point of the news is that Southbound funds have reduced their holdings in Sensong International (02155.HK) by 218,000 shares on December 22, 2025, marking a trend of net reductions over recent trading days [1] - Over the past five trading days, Southbound funds have reduced their holdings for four days, with a total net reduction of 326,000 shares [1] - In the last twenty trading days, there have been fifteen days of reductions, totaling a net decrease of 9.319 million shares [1] Group 2 - As of now, Southbound funds hold 190 million shares of Sensong International, which represents 15.28% of the company's total issued ordinary shares [1] - The company specializes in the manufacturing of pressure equipment and provides comprehensive pressure equipment solutions, including traditional and modular pressure equipment [2] - Traditional pressure equipment includes heat exchangers, vessels, reactors, and towers, while modular pressure equipment consists of process modules and skids, as well as modular plants [2]